Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Pfizer Inc (CIK 78003) reported $238.8M across 17 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: ORIC ($57.7M, 24.14%), ALLO ($49.8M, 20.85%), ARVN ($34.9M, 14.63%), CELC ($31.3M, 13.13%), ZURA ($16.8M, 7.05%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ORIC | ORIC PHARMACEUTICALS INC | $57.7M | 24.14% | 4.8M | Trimmed |
| 2 | ALLO | ALLOGENE THERAPEUTICS INC | $49.8M | 20.85% | 22.0M | Hold |
| 3 | ARVN | ARVINAS INC | $34.9M | 14.63% | 3.5M | Hold |
| 4 | CELC | CELCUITY INC | $31.3M | 13.13% | 295,652 | Trimmed |
| 5 | ZURA | ZURA BIO LTD | $16.8M | 7.05% | 2.8M | Trimmed |
| 6 | WVE | WAVE LIFE SCIENCES LTD | $11.9M | 5.00% | 1.9M | Hold |
| 7 | PYXS | PYXIS ONCOLOGY INC | $9.2M | 3.86% | 7.0M | Hold |
| 8 | CRBU | CARIBOU BIOSCIENCES INC | $8.3M | 3.50% | 4.7M | Hold |
| 9 | SPRO | SPERO THERAPEUTICS INC | $5.5M | 2.31% | 2.4M | Hold |
| 10 | BHVN | BIOHAVEN LTD | $4.2M | 1.77% | 505,645 | Hold |
| 11 | CRDF | CARDIFF ONCOLOGY INC | $3.7M | 1.57% | 2.4M | Hold |
| 12 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $2.0M | 0.84% | 953,834 | Hold |
| 13 | NXTC | NEXTCURE INC | $1.5M | 0.64% | 153,354 | Trimmed |
| 14 | AGOMAB THERAPEUTICS NV | $813,750 | 0.34% | 75,000 | New | |
| 15 | QTTB | Q32 BIO INC | $736,731 | 0.31% | 101,618 | Trimmed |
| 16 | BOLT | BOLT BIOTHERAPEUTICS INC | $137,116 | 0.06% | 31,305 | Hold |
| 17 | DNA | GINKGO BIOWORKS HOLDINGS INC | $17,363 | 0.01% | 2,928 | Hold |
| 18 | SENS | SENSEONICS HLDGS INC | $14,242 | 0.01% | 2,171 | Hold |
| 19 | ANTX | AN2 THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-03-31